TrialThe Lancet. Oncology2010

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.

David N Krag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.